Ernexa Therapeutics Inc. Income Statement
ERNA|13 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Ernexa Therapeutics Inc. reported $582,000 in revenue and $45M in net loss for FY2025. Revenue has declined at a 23.6% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $582.0K | $68.0K | $0 | $19.8M | $23.3M | $21.3M | $22.3M | $24.5M | $26.0M | $23.7M | $24.1M | $23.9M | $25.3M |
| Cost of Revenue | $96.0K | $236.0K | $0 | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | $486.0K | -$168.0K | $0 | - | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $13.1M | $14.6M | $16.8M | $13.2M | $14.5M | $15.6M | $16.5M | $18.1M | $18.4M | $16.2M | $18.2M | $20.4M | $18.9M |
| R&D Expense | $4.6M | $5.9M | $10.4M | $26.0K | $72.0K | $139.0K | - | - | - | - | - | - | - |
| Operating Income | -$15.7M | -$21.1M | -$33.2M | -$1.8M | $203.0K | -$1.4M | -$2.3M | -$6.9M | -$4.7M | -$1.1M | -$1.1M | -$3.3M | -$325.0K |
| Interest Expense | $174.0K | $176.0K | $30.0K | $236.0K | $296.0K | $425.0K | $517.0K | $283.0K | $210.0K | $26.0K | $44.0K | $52.0K | $101.0K |
| Income Tax | $30.0K | -$3.0K | $45.0K | $27.0K | -$64.0K | $66.0K | $38.0K | $12.0K | $84.0K | $46.0K | -$83.0K | $163.0K | $42.0K |
| Net Income | -$44.5M | -$21.7M | -$24.6M | -$2.0M | -$259.0K | -$1.1M | -$2.9M | -$7.2M | -$5.0M | -$1.1M | -$995.0K | -$3.4M | -$400.0K |
| EPS (Basic) | -$48.96 | -$4.08 | -$8.06 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$48.96 | -$4.08 | -$8.06 | -$0.72 | -$0.10 | -$0.45 | -$1.54 | -$3.93 | -$0.06 | -$0.01 | -$0.01 | -$0.06 | -$0.01 |
| Shares Outstanding | 3.4M | 5.4M | 5.1M | 2.9M | 2.9M | 2.5M | 92.4M | 1.8M | 92.4M | 78.6M | 71.1M | 60.9K | 60.8K |
| Gross Margin | 83.5% | -247.1% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | -2693.1% | -31080.9% | - | -8.9% | 0.9% | -6.6% | -10.2% | -28.1% | -18.2% | -4.7% | -4.4% | -13.7% | -1.3% |
| Profit Margin | -7652.8% | -31864.7% | - | -10.3% | -1.1% | -5.1% | -13.1% | -29.5% | -19.3% | -4.4% | -4.1% | -14.3% | -1.6% |